SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-22-009322
Filing Date
2022-09-02
Accepted
2022-09-02 20:05:33
Documents
1
Period of Report
2022-07-08

Document Format Files

Seq Description Document Type Size
1 form4a-09022022_080925.html 4/A  
1 form4a-09022022_080925.xml 4/A 3776
  Complete submission text file 0001415889-22-009322.txt   5182
Mailing Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753
Business Address 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 650-249-9090
Natera, Inc. (Issuer) CIK: 0001604821 (see all company filings)

IRS No.: 010894487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET, SUITE B1-1 CAMBRIDGE MA 02141
Business Address
Bertagnolli Monica (Reporting) CIK: 0001761030 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37478 | Film No.: 221226611